BIIB vs SNA · P/E 21, rev $9.89B vs P/E 17, rev $1.33B
Biogen Inc (BIIB) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the BIIB and SNA stock pages for the full models.
Not investment advice.